• HOME
  • ABOUT
    • ABOUT
    • PLATFORM
    • PIPELINE
  • COLLABORATIONS
  • SERVICES
  • CAREERS
  • NEWS
  • CONTACT
    • CONTACT
    • COOKIE POLICY (EU)

Cortalix and UMCG join forces to develop next-generation nanobody-based CAR-T therapies

by admin C | Jul 1, 2025 | News

Cortalix has entered into a New Collaboration with University Medical Center Groningen, The Netherlands: Development of AI-Guided nano-CAR™ Library for Next-Generation CAR-T Therapy Cortalix has initiated a public-private research collaboration with the Department of...

CORTALIX will be present at Antibody Industrial Symposium (AIS) in Tours, France, June 25-26 2025

by admin C | Jun 4, 2025 | News, Uncategorized

CORTALIX AIS 2025 – Booth #51 We’re excited to announce that Cortalix will be present at the 13th Antibody Industrial Symposium (AIS 2025), taking place June 25–26 at the Palais des Congrès in Tours, France. 📍 Booth #51👤 Herman Steen (CEO) and Ronald Vos (CBO) will be...

Cortalix joins forces with Portal Biotech, GECCO and RUG to enable portable nanobody-based diagnostics

by admin C | May 5, 2025 | News

Cortalix is pleased to announce its participation in a new EFRO-funded research collaboration with Portal Biotech, GECCO Biotech, and the University of Groningen (RUG). The project aims to develop a portable diagnostic platform based on innovative nanopore technology,...

Cortalix receives investment from Future Tech Ventures and Rabobank Innovation

by admin C | Mar 3, 2025 | News

Cortalix, a Groningen-based biotech start-up has received an investment of 1 million euros from Future Tech Ventures, the Rabobank Innovation Loan, and various subsidies to accelerate the development and commercialization of its single-domain antibody technology. The...

Cortalix will present at PepTalk San Diego, CA, January 13-16 2025

by admin C | Jan 13, 2025 | News

Herman Steen, CEO of Cortalix, will present on “Single-Domain Antibody-Based Radiopharmaceuticals for Novel Cancer Stroma Targets” at the 24th Annual PepTalk Summit US, January 13-16, 2025 in San Diego, CA. For more information about Cortalix:...

Cortalix will present at Festival of Biologics in Basel, Switzerland, 15-17 October 2024

by admin C | Oct 15, 2024 | News

Herman Steen, CEO of Cortalix, will present a poster “A Synthetic Single-domain Antibody Discovery Platform for the Selection of Radiopharmaceuticals for Novel Fibrosis Targets” at the Festival of Biologics, October 15-17, 2024 in Basel, Switzerland. You...
« Older Entries

Recent Posts

  • Cortalix and UMCG join forces to develop next-generation nanobody-based CAR-T therapies
  • CORTALIX will be present at Antibody Industrial Symposium (AIS) in Tours, France, June 25-26 2025
  • No new internships available for 2025.
  • Cortalix joins forces with Portal Biotech, GECCO and RUG to enable portable nanobody-based diagnostics
  • Cortalix receives investment from Future Tech Ventures and Rabobank Innovation

Recent Comments

No comments to show.

CORTALIX BV
Innolab AVEBE
Zernikelaan 8
9747 AA Groningen
The Netherlands

© 2025 All rights reserved – Cortalix BV

Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
View preferences
{title} {title} {title}